TY - JOUR T1 - Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer JF - bioRxiv DO - 10.1101/450049 SP - 450049 AU - Victoria H. Cruz AU - Emily N. Arner AU - Wenting Du AU - Alberto E. Bremauntz AU - Rolf A. Brekken Y1 - 2018/01/01 UR - http://biorxiv.org/content/early/2018/10/22/450049.abstract N2 - Pancreatic ductal adenocarcinoma (PDA) is characterized by an activating mutation in KRAS, which is critical for the biology of PDA progression. Direct inhibition of KRAS through pharmacological means remains a challenge; however, targeting key KRAS effectors has therapeutic potential. We investigated the contribution of TANK-binding kinase 1 (TBK1), a critical downstream effector of mutant active KRAS, to PDA progression. We report that higher levels of TBK1 mRNA are associated with poorer overall survival in human PDA patients and that TBK1 supports the growth and metastasis of KRAS-mutant PDA by driving an epithelial plasticity program in tumor cells that enhances invasive and metastatic capacity. Further, we identify that the receptor tyrosine kinase Axl induces TBK1 activity in a Ras-RalB-dependent manner. These findings demonstrate that TBK1 is central to an Axl-driven epithelial-mesenchymal transition in KRAS-mutant PDA and suggest that interruption of the Axl-TBK1 signaling cascade above or below KRAS has potential therapeutic efficacy in this recalcitrant disease. ER -